KSAT 12: Long-awaited new ALS drug shows promise at UT Health San Antonio

Dr. Carlayne Jackson, professor of neurology and otolaryngology, co-authored a new study that includes the results of a small clinical trial for an oral drug that slowed ALS patients’ rate of functional decline.

Read and watch the story.

Share This Article!